As specialized pipelines become the primary growth engine for the biopharma industry, traditional commercial playbooks often fail to reach ultra-small patient populations. This invitation-only summit focuses on actionable strategies, including diagnostic acceleration, AI-driven micro-audience targeting, and the integration of non-profit advocacy ecosystems. By moving away from broad-reach tactics, the collaboration seeks to provide a dedicated forum for senior executives to navigate the complexities of high-touch caregiver experiences and generalist physician engagement.

Olivier Chateau, CEO of Health Union, and Bob Ehrlich, CEO of DTC Perspectives, designed the forum to address the shift toward hyper-targeted commercialization. The Boston meeting serves as the foundation for a broader initiative, which will expand in June 2027 to include a dedicated workshop and awards ceremony held during the annual DTC National Conference. Registration for the November event is strictly limited to ensure an environment focused on executive peer-to-peer exchange.